Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Phase 1 trial of ALRN-6924, a dual inhibitor of MDMX and MDM2, in patients with solid tumors and lymphomas bearing wild-type TP53
Water, L-carnitine (7%), acid (citric acid), flavouring, preservatives (sorbic acid, sodium benzoate), D-pantothenate, calcium, sweeteners (acesulfame K, sucralose), chromium (III) chloride (0.2%), colours (carotenes, quinoline yellow1, brilliant blue FCF)
TB-500 TB-500 is a synthetic peptide corresponding to the active region of Thymosin Beta-4, a protein involved in actin regulation
Cardiovascular disease: risk assessment and reduction, including lipid modification (NG238)
US$ 27.89
US$ 24.97
US$ 29.18
US$ 28.53
US$ 29.21
